For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...
Medically reviewed by Patricia Mikula, PharmD Key Takeaways GLP-1 agonists help curb appetite, keep you full, and reduce food intake. The amount of weight you can expect to lose on peptides ...
For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Glucagon-like peptide-1 agonists were not associated ...
A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving ...
LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical company focused on the research and development of ...
ASC37, a GLP-1R/GIPR/GCGR triple peptide agonist, was discovered and developed in-house utilizing Ascletis' Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD) and ...
C-peptide, a 31–amino acid peptide originally regarded as an inert by‐product of insulin synthesis, is emerging as a key modulator of diabetic complications. Secreted in equimolar amounts with insulin ...
What is the role of C peptide in managing uncontrolled type 2 diabetes? —Ndukwe H. Odeluga, MD, Bakersfield, Calif. Cleaved from proinsulin to make mature insulin, C peptide can be considered a marker ...
This article was reviewed by Lynn Marie Morski, MD, JD Key Takeaways: Peptides are compounds made of amino acids linked by ...
A little wiggle room might be just what the doctor ordered. New research suggests that the peptides—short chunks of protein—used to treat Type 2 diabetes may be more effective if they're able to ...
Dr Anne Peters discusses updates in the ADA 2026 Standards of Care in Diabetes, focusing on the use of technology.